Northern Trust’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-570,989
| Closed | -$45.6M | – | 4661 |
|
|
2021
Q1 | $45.6M | Sell |
570,989
-10,107
| -2% | -$789K | 0.01% | 1185 |
|
|
2020
Q4 | $45.8M | Sell |
581,096
-20,843
| -3% | -$1.22M | 0.01% | 1140 |
|
|
2020
Q3 | $26.4M | Sell |
601,939
-30,989
| -5% | -$1.53M | 0.01% | 1414 |
|
|
2020
Q2 | $28M | Buy |
632,928
+262,643
| +71% | +$9.8M | 0.01% | 1342 |
|
|
2020
Q1 | $13.3M | Buy |
370,285
+2,788
| +0.8% | +$159K | ﹤0.01% | 1699 |
|
|
2019
Q4 | $26.1M | Buy |
367,497
+8,860
| +2% | +$643K | 0.01% | 1518 |
|
|
2019
Q3 | $26.8M | Sell |
358,637
-8,624
| -2% | -$731K | 0.01% | 1448 |
|
|
2019
Q2 | $29.6M | Buy |
367,261
+4,733
| +1% | +$333K | 0.01% | 1398 |
|
|
2019
Q1 | $24.2M | Buy |
362,528
+38,492
| +12% | +$2.92M | 0.01% | 1523 |
|
|
2018
Q4 | $24.1M | Sell |
324,036
-104,475
| -24% | -$8.63M | 0.01% | 1421 |
|
|
2018
Q3 | $39.4M | Sell |
428,511
-8,059
| -2% | -$768K | 0.01% | 1208 |
|
|
2018
Q2 | $42.9M | Sell |
436,570
-295,751
| -40% | -$33.1M | 0.01% | 1141 |
|
|
2018
Q1 | $81.6M | Sell |
732,321
-64,175
| -8% | -$7.19M | 0.02% | 649 |
|
|
2017
Q4 | $81.9M | Sell |
796,496
-9,399
| -1% | -$936K | 0.02% | 654 |
|
|
2017
Q3 | $75.9M | Buy |
805,895
+5,664
| +0.7% | +$447K | 0.02% | 689 |
|
|
2017
Q2 | $62.3M | Buy |
800,231
+26,883
| +3% | +$2.02M | 0.02% | 766 |
|
|
2017
Q1 | $61.9M | Buy |
773,348
+6,486
| +0.8% | +$515K | 0.02% | 770 |
|
|
2016
Q4 | $60.4M | Buy |
766,862
+5,777
| +0.8% | +$449K | 0.02% | 746 |
|
|
2016
Q3 | $59.3M | Sell |
761,085
-1,619
| -0.2% | -$117K | 0.02% | 740 |
|
|
2016
Q2 | $52.4M | Buy |
762,704
+14,624
| +2% | +$1.01M | 0.02% | 786 |
|
|
2016
Q1 | $53.4M | Buy |
748,080
+6,221
| +0.8% | +$390K | 0.02% | 766 |
|
|
2015
Q4 | $46.1M | Sell |
741,859
-5,518
| -0.7% | -$337K | 0.02% | 858 |
|
|
2015
Q3 | $42.4M | Buy |
747,377
+11,186
| +2% | +$592K | 0.01% | 927 |
|
|
2015
Q2 | $39.5M | Sell |
736,191
-8,913
| -1% | -$434K | 0.01% | 1041 |
|
|
2015
Q1 | $35.4M | Buy |
745,104
+11,337
| +2% | +$502K | 0.01% | 1128 |
|
|
2014
Q4 | $31.7M | Sell |
733,767
-2,323
| -0.3% | -$94.9K | 0.01% | 1171 |
|
|
2014
Q3 | $25.3M | Buy |
736,090
+11,352
| +2% | +$401K | 0.01% | 1317 |
|
|
2014
Q2 | $26.5M | Sell |
724,738
-31,237
| -4% | -$1.06M | 0.01% | 1286 |
|
|
2014
Q1 | $25.5M | Sell |
755,975
-342,033
| -31% | -$11.3M | 0.01% | 1363 |
|
|
2013
Q4 | $37.2M | Buy |
1,098,008
+325,179
| +42% | +$11.3M | 0.01% | 996 |
|
|
2013
Q3 | $24.6M | Sell |
772,829
-116,595
| -13% | -$3.1M | 0.01% | 1288 |
|
|
2013
Q2 | $20.1M | Buy |
+889,424
| New | +$19.3M | 0.01% | 1379 |
|
Northern Trust's CMD Position: Q2 2021 in Review
Northern Trust sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 570,989 shares — an estimated $45.6M sold.
Northern Trust first reported a position in CMD in Q2 2013 and held it in 32 quarters. The position peaked at $81.9M in Q4 2017. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.
- Northern Trust reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
- Northern Trust sold 570,989 Cantel Medical Corporation shares in Q2 2021, an estimated $45.6M.
- Northern Trust first reported a position in Cantel Medical Corporation in Q2 2013 and held it in 32 quarters.
- Northern Trust's Cantel Medical Corporation position peaked at $81.9M in Q4 2017.
- 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.
Based on Northern Trust's 13F filing for Q2 2021, filed 13 Aug 2021.